DE69813247D1 - Verbindungen zur verwendung in der krebsbehandlung - Google Patents
Verbindungen zur verwendung in der krebsbehandlungInfo
- Publication number
- DE69813247D1 DE69813247D1 DE69813247T DE69813247T DE69813247D1 DE 69813247 D1 DE69813247 D1 DE 69813247D1 DE 69813247 T DE69813247 T DE 69813247T DE 69813247 T DE69813247 T DE 69813247T DE 69813247 D1 DE69813247 D1 DE 69813247D1
- Authority
- DE
- Germany
- Prior art keywords
- lesion
- cancer
- compounds
- connections
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 201000011510 cancer Diseases 0.000 title abstract 4
- 230000003902 lesion Effects 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 108700026226 TATA Box Proteins 0.000 abstract 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 229910052797 bismuth Inorganic materials 0.000 abstract 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 230000005292 diamagnetic effect Effects 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 150000002500 ions Chemical class 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 229910052712 strontium Inorganic materials 0.000 abstract 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000011701 zinc Substances 0.000 abstract 1
- 229910052725 zinc Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/94—Bismuth compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F3/003—Compounds containing elements of Groups 2 or 12 of the Periodic Table without C-Metal linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3510197P | 1997-01-14 | 1997-01-14 | |
| PCT/US1998/000400 WO1998030555A1 (en) | 1997-01-14 | 1998-01-12 | Treatment for cancer and compounds for use therewith |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE69813247D1 true DE69813247D1 (de) | 2003-05-15 |
Family
ID=21880651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69813247T Expired - Lifetime DE69813247D1 (de) | 1997-01-14 | 1998-01-12 | Verbindungen zur verwendung in der krebsbehandlung |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US6294678B1 (de) |
| EP (1) | EP1007519B1 (de) |
| AT (1) | ATE236892T1 (de) |
| AU (1) | AU6239198A (de) |
| CA (1) | CA2278159A1 (de) |
| DE (1) | DE69813247D1 (de) |
| WO (1) | WO1998030555A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2181586B1 (es) * | 2001-05-03 | 2004-06-16 | Alfonso Blanco Cobo | Producto farmaceutico para el tratamiento de tumores cancerigenos. |
| AU2002360383A1 (en) * | 2001-11-13 | 2003-05-26 | Alchemy International | Use of compounds comprising iodine, strontium and ascorbic acid as well as either bismuth, zinc or potassium in the treatment of aids |
| CN103554070A (zh) * | 2013-11-08 | 2014-02-05 | 李玉成 | 抗坏血酸氧铋、其制备方法及应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2400171A (en) | 1935-09-26 | 1946-05-14 | Frances R Ruskin | Stabilized metal ascorbates |
| GB488784A (en) | 1936-11-13 | 1938-07-13 | Simon Lyon Ruskin | Production of metal compounds of ascorbic acid |
| US2259492A (en) | 1938-05-28 | 1941-10-21 | Simon L Ruskin | Therapeutic preparation of bismuth and method of preparing same |
| US2312195A (en) | 1939-10-20 | 1943-02-23 | Simon L Ruskin | Salts of dextro-ascorbic acid and method of preparing same |
| US2427692A (en) | 1940-07-29 | 1947-09-23 | Frances R Ruskin | Therapeutic metal cevitamate compositions |
| US5626883A (en) * | 1994-04-15 | 1997-05-06 | Metagenics, Inc. | Ascorbic acid compositions providing enhanced human immune system activity |
| US5639787A (en) | 1995-02-28 | 1997-06-17 | The Center For The Improvement Of Human Functioning Int'l, Inc. | Therapeutic method for the treatment of cancer |
| CN1208041A (zh) * | 1995-11-28 | 1999-02-17 | 北京市潮白河新技术研究所 | 抗坏血酸衍生物 |
-
1998
- 1998-01-12 AT AT98904538T patent/ATE236892T1/de not_active IP Right Cessation
- 1998-01-12 CA CA002278159A patent/CA2278159A1/en not_active Abandoned
- 1998-01-12 AU AU62391/98A patent/AU6239198A/en not_active Abandoned
- 1998-01-12 EP EP98904538A patent/EP1007519B1/de not_active Expired - Lifetime
- 1998-01-12 US US09/005,996 patent/US6294678B1/en not_active Expired - Fee Related
- 1998-01-12 WO PCT/US1998/000400 patent/WO1998030555A1/en not_active Ceased
- 1998-01-12 DE DE69813247T patent/DE69813247D1/de not_active Expired - Lifetime
-
2001
- 2001-05-07 US US09/850,524 patent/US20020037327A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998030555A1 (en) | 1998-07-16 |
| AU6239198A (en) | 1998-08-03 |
| CA2278159A1 (en) | 1998-07-16 |
| US20020037327A1 (en) | 2002-03-28 |
| EP1007519B1 (de) | 2003-04-09 |
| ATE236892T1 (de) | 2003-04-15 |
| US6294678B1 (en) | 2001-09-25 |
| EP1007519A1 (de) | 2000-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2199117A1 (en) | Compounds and methods for the treatment of cancer | |
| MX9605665A (es) | Bis (resorcinil) triazinas. | |
| IL83153A0 (en) | Substituted imidazoles,their preparation and pharmaceutical compositions containing them | |
| PT923570E (pt) | Amidas de acidos piridil-alcenoicos e piridil-alcinicos como agentes citostaticos e imunossupressivos | |
| TR199901971T2 (xx) | Bir resept�re ba�lanan peptidler ve bile�ikler. | |
| ZW24786A1 (en) | Insecticidal pyrazolines | |
| EP0643775A4 (de) | Therapeutische zusammensetzungen. | |
| ATE319712T1 (de) | Hydantoin derivate, pharmazeutische zusammensetzungen und verfahren zu ihrer verwendung | |
| HUT37712A (en) | Fungicide compositions containing imidazole or triazole derivative as active substance and process for preparing the active substances | |
| DE3376295D1 (en) | Pharmaceutical composition containing adenosine derivatives for use in treating tumours | |
| GR3024379T3 (en) | Peptides with organo-protective activity, the process for preparing them and their use in therapy | |
| ES8403157A1 (es) | Un metodo de preparar sustancias biologicamente activas que tienen actividad anti-tumoral. | |
| ATE314065T1 (de) | Threitol-buttersäureester-enthaltende zusammensetzungen und ihre verwendung | |
| DE69813247D1 (de) | Verbindungen zur verwendung in der krebsbehandlung | |
| ATE264309T1 (de) | Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren | |
| IL118218A0 (en) | Terpenoidic derivatives and pharmaceutical compositions containing them | |
| DE69814691D1 (de) | Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten | |
| DE3577550D1 (de) | Aminocarbonsaeurekomplexe zur behandlung von knochentumoren. | |
| IN181999B (de) | ||
| EP0246982A3 (en) | Triazole or imidazole and tetrahydrofuran compounds, their use as fungicides and preparation processes | |
| HUT44515A (en) | Process for producing isoquinolinol compounds of heart activity increasing, phosphodiesterase iii inhibiting and/or renal vasodilating activity and pharmaceutical composition containing them | |
| ES8404183A1 (es) | Un procedimiento para la preparacion de composiciones farmaceuticas orales de acido propionhidroxamico. | |
| DE3374066D1 (en) | N-acyl derivatives of peptides, their manufacture and use in combating diseases and means therefor | |
| DE3576155D1 (de) | Diazohydroxypyrazinverbindungen, verfahren zu deren herstellung und verwendung. | |
| UA29004A (uk) | Спосіб лікування сепсису |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8332 | No legal effect for de |